Interviews
News Flash
Applied DNA & Colorcon launch On-Dose Authentication
24 Dec '19
2 min read
Pic: Applied DNA
Applied DNA and its partner, Colorcon, a leader in the development and supply of film coating systems and excipients, have launched the On-Dose Authentication capability to provide track and trace functionality for supply chain security. Applied DNA, headquartered in the US, is a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing.
The seamless integration of molecular taggants from Applied DNA Sciences (ADNAS) into an Opadry fully formulated film coating system significantly reduces the risks associated with counterfeit and falsified medications entering the supply chain.
This first commercial offering is the culmination of extensive collaboration between Colorcon and ADNAS to help pharmaceutical companies enhance patient safety and reduce risk by using intelligent data and analytics gathered from authentication of the dosage form itself. By better understanding the vulnerabilities of a complex global supply chain, drug manufacturers can make informed decisions regarding distribution networks and deploy preventative measures to address counterfeiting and product diversion issues, Applied DNA said in a press release.
“With new guidelines from regulators and accessible technology, on-dose solutions provide a more robust and reliable means of identifying and deterring counterfeiting, verifying product authenticity, and ensuring product traceability. Through extensive research and development, Colorcon has created a unique coating system to address this global problem,” Ali Rajabi-Siahboomi, vice president/chief scientific officer at Colorcon said.
“On-dose authentication technology represents the next generation in pharmaceutical supply-chain security by providing a powerful tool for tracking product from plant to patient. By seamlessly enabling authentication, these digitised coatings confirm the quality and origin of medicines thereby safeguarding both patients and brands,” Kelly Boyer, general manager, film coatings at Colorcon said.
Colorcon continues to advance technologies and services to meet industry challenges with innovative solutions. This latest technology yet again demonstrates Colorcon’s leadership in responding to the needs of the pharmaceutical industry, bringing novel solutions that are efficient to deliver with dependable performance.
The seamless integration of molecular taggants from Applied DNA Sciences (ADNAS) into an Opadry fully formulated film coating system significantly reduces the risks associated with counterfeit and falsified medications entering the supply chain.
This first commercial offering is the culmination of extensive collaboration between Colorcon and ADNAS to help pharmaceutical companies enhance patient safety and reduce risk by using intelligent data and analytics gathered from authentication of the dosage form itself. By better understanding the vulnerabilities of a complex global supply chain, drug manufacturers can make informed decisions regarding distribution networks and deploy preventative measures to address counterfeiting and product diversion issues, Applied DNA said in a press release.
“With new guidelines from regulators and accessible technology, on-dose solutions provide a more robust and reliable means of identifying and deterring counterfeiting, verifying product authenticity, and ensuring product traceability. Through extensive research and development, Colorcon has created a unique coating system to address this global problem,” Ali Rajabi-Siahboomi, vice president/chief scientific officer at Colorcon said.
“On-dose authentication technology represents the next generation in pharmaceutical supply-chain security by providing a powerful tool for tracking product from plant to patient. By seamlessly enabling authentication, these digitised coatings confirm the quality and origin of medicines thereby safeguarding both patients and brands,” Kelly Boyer, general manager, film coatings at Colorcon said.
Colorcon continues to advance technologies and services to meet industry challenges with innovative solutions. This latest technology yet again demonstrates Colorcon’s leadership in responding to the needs of the pharmaceutical industry, bringing novel solutions that are efficient to deliver with dependable performance.
Fibre2Fashion News Desk (GK)
Popular News
Leave your Comments
Editor’s Pick
Esteemed Clients
-Ltd..jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Thermore (Far East) Ltd.")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Telangana State Industrial Infrastructure Corporation Limited (TSllC Ltd)")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Taiwan Textile Federation (TTF)")
